Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
LGND
LGND
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
LGND News
Ligand Pharmaceuticals Executive Exercises Stock Options
9h ago
NASDAQ.COM
Ligand Pharmaceuticals Executive Sells Stock Options for $1.03 Million
10h ago
Fool
Ligand Pharmaceuticals CFO Sells $688,000 in Stock
3d ago
Fool
BofA Initiates Coverage on Ligand Pharmaceuticals with Buy Rating
Mar 11 2026
Benzinga
LIGAND PHARMACEUTICALS INC: BOFA GLOBAL RESEARCH STARTS COVERAGE WITH A BUY RATING AND A TARGET PRICE OF $244
Mar 11 2026
moomoo
Bank of America Initiates Buy on Ligand Pharmaceuticals with $244 Target
Mar 11 2026
seekingalpha
Latest Wall Street Rating Updates
Mar 11 2026
CNBC
Rice Hall James Increases Stake in QuidelOrtho
Mar 09 2026
Fool
Rice Hall James Increases Stake in QuidelOrtho
Mar 09 2026
NASDAQ.COM
Rice Hall James Increases Stake in Stride by 122,430 Shares
Mar 09 2026
Fool
Ligand Pharmaceuticals Reports Strong Q4 2025 Earnings and Growth Outlook
Feb 26 2026
seekingalpha
Ligand Pharmaceuticals Reports Strong 2025 Financial Performance with 48% Royalty Revenue Growth
Feb 26 2026
Newsfilter
Ligand Pharmaceuticals Releases 2026 Financial Guidance
Feb 26 2026
seekingalpha
Ligand Pharmaceuticals Set to Announce Q4 Earnings on February 26
Feb 25 2026
seekingalpha
S&P 500 and Dow Reverse Gains as Nasdaq Narrows Upturn
Jan 08 2026
Yahoo Finance
S&P 500 and Dow Retreat from Highs, Eli Lilly and Google Flash Buy Signals
Jan 08 2026
Yahoo Finance
Show More News
